# Docusign, Inc.: Form 10-Q for the period ended Jul 31, 2019

- Company: [Docusign, Inc.](/companies/docu.md) (CIK 1261333)
- Form: 10-Q
- Filed: 2019-09-06
- Accepted by EDGAR: Sep 6, 2019, 16:23 ET
- Period: 2019-07-31
- Accession: 0001261333-19-000077
- Inline XBRL: yes
- Main document: https://www.sec.gov/Archives/edgar/data/1261333/000126133319000077/q22010q.htm
- All documents and exhibits: https://www.sec.gov/Archives/edgar/data/1261333/000126133319000077/

## Figures reported in this filing

Standardized XBRL line items for the period ended 2019-07-31.

| Line item | Period | Value | XBRL concept |
| --- | --- | ---: | --- |
| Revenue | 3 months, 2019-05-01 to 2019-07-31 | $235.6m | us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax |
| Revenue | 6 months, 2019-02-01 to 2019-07-31 | $449.6m | us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax |
| Cost of revenue | 3 months, 2019-05-01 to 2019-07-31 | $61.2m | us-gaap:CostOfGoodsAndServicesSold |
| Cost of revenue | 6 months, 2019-02-01 to 2019-07-31 | $113.2m | us-gaap:CostOfGoodsAndServicesSold |
| Gross profit | 3 months, 2019-05-01 to 2019-07-31 | $174.4m | us-gaap:GrossProfit |
| Gross profit | 6 months, 2019-02-01 to 2019-07-31 | $336.4m | us-gaap:GrossProfit |
| Research and development | 3 months, 2019-05-01 to 2019-07-31 | $47.5m | us-gaap:ResearchAndDevelopmentExpense |
| Research and development | 6 months, 2019-02-01 to 2019-07-31 | $84.7m | us-gaap:ResearchAndDevelopmentExpense |
| Operating income | 3 months, 2019-05-01 to 2019-07-31 | −$64.7m | us-gaap:OperatingIncomeLoss |
| Operating income | 6 months, 2019-02-01 to 2019-07-31 | −$107.2m | us-gaap:OperatingIncomeLoss |
| Interest expense | 3 months, 2019-05-01 to 2019-07-31 | $7.3m | us-gaap:InterestExpense |
| Interest expense | 6 months, 2019-02-01 to 2019-07-31 | $14.4m | us-gaap:InterestExpense |
| Income tax | 3 months, 2019-05-01 to 2019-07-31 | $1.2m | us-gaap:IncomeTaxExpenseBenefit |
| Income tax | 6 months, 2019-02-01 to 2019-07-31 | $2.5m | us-gaap:IncomeTaxExpenseBenefit |
| Net income | 3 months, 2019-05-01 to 2019-07-31 | −$68.6m | us-gaap:NetIncomeLoss |
| Net income | 6 months, 2019-02-01 to 2019-07-31 | −$114.4m | us-gaap:NetIncomeLoss |
| Diluted EPS | 3 months, 2019-05-01 to 2019-07-31 | −$0.39 | us-gaap:EarningsPerShareBasicAndDiluted |
| Diluted EPS | 6 months, 2019-02-01 to 2019-07-31 | −$0.66 | us-gaap:EarningsPerShareBasicAndDiluted |
| Operating cash flow | 6 months, 2019-02-01 to 2019-07-31 | $72.1m | us-gaap:NetCashProvidedByUsedInOperatingActivities |
| Capital expenditure | 6 months, 2019-02-01 to 2019-07-31 | $29.8m | us-gaap:PaymentsToAcquirePropertyPlantAndEquipment |
| Cash and equivalents | at 2019-07-31 | $224.3m | us-gaap:CashAndCashEquivalentsAtCarryingValue |
| Current assets | at 2019-07-31 | $943.5m | us-gaap:AssetsCurrent |
| Total assets | at 2019-07-31 | $1.76bn | us-gaap:Assets |
| Current liabilities | at 2019-07-31 | $574.1m | us-gaap:LiabilitiesCurrent |
| Total liabilities | at 2019-07-31 | $1.20bn | us-gaap:Liabilities |
| Shareholders' equity | at 2019-07-31 | $566.7m | us-gaap:StockholdersEquity |

## Sections

The sections of this filing are being extracted from EDGAR and appear here in about a minute. Meanwhile, read the original on sec.gov. https://www.sec.gov/Archives/edgar/data/1261333/000126133319000077/q22010q.htm

Filed Sep 6, 2019.
Source: SEC EDGAR, the filing index for accession 0001261333-19-000077. Last ingested by Listed: Nov 5, 2026, 13:21 ET. No prices; not investment advice.
